132 related articles for article (PubMed ID: 11095963)
1. Modeling a prion protein dimer: predictions for fibril formation.
Warwicker J
Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
[TBL] [Abstract][Full Text] [Related]
2. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
3. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
4. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
5. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
6. NMR structure of the mouse prion protein domain PrP(121-231).
Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous conformational change within the prion protein--implications for disease pathogenesis?
Jackson GS
Bioessays; 2001 Sep; 23(9):772-4. PubMed ID: 11536289
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
9. Species barriers in a model for specific prion protein dimerisation.
Warwicker J
Biochem Biophys Res Commun; 1997 Mar; 232(2):508-12. PubMed ID: 9125211
[TBL] [Abstract][Full Text] [Related]
10. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
[TBL] [Abstract][Full Text] [Related]
11. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
Havsteen BH
J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
[TBL] [Abstract][Full Text] [Related]
12. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
13. The toxicity of prion protein fragment PrP(106-126) is not mediated by membrane permeabilization as shown by a M112W substitution.
Henriques ST; Pattenden LK; Aguilar MI; Castanho MA
Biochemistry; 2009 May; 48(19):4198-208. PubMed ID: 19301918
[TBL] [Abstract][Full Text] [Related]
14. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
15. Autocatalytic self-propagation of misfolded prion protein.
Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
[TBL] [Abstract][Full Text] [Related]
16. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
17. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
Guest WC; Plotkin SS; Cashman NR
J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
Masel J; Genoud N; Aguzzi A
J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
[TBL] [Abstract][Full Text] [Related]
19. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
20. Prion and doppel proteins bind to granule cells of the cerebellum.
Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
